Skip to main content

Lab Notes: Chimeron Bio names new CEO; Amicus Therapeutics gets positive opinion for rare disease therapy

A Philadelphia biotechnology company has named a new CEO, while a Montgomery County firm gave an update on its lead personalized therapeutic cancer vaccine.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.